Apter L - Search Results

1

Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer.

Leshem Y, Dolev Y, Siegelmann-Danieli N, Sharman Moser S, Apter L, Chodick G, Nikolaevski-Berlin A, Shamai S, Merimsky O, Wolf I. Leshem Y, et al. Among authors: apter l. Cancer. 2023 Sep 15;129(18):2789-2797. doi: 10.1002/cncr.34918. Epub 2023 Jun 24. Cancer. 2023. PMID: 37354065 Free article.

2

Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel.

Moser SS, Apter L, Arunachalam A, Burke T, Shalev V, Chodick G, Siegelmann-Danieli N. Moser SS, et al. Among authors: apter l. Immunotherapy. 2021 Jul;13(10):851-861. doi: 10.2217/imt-2020-0347. Epub 2021 May 26. Immunotherapy. 2021. PMID: 34034511 Free article.

3

Predictors of treatment initiation and mapping the cancer diagnostic pathway: A retrospective observational cohort study of patients with metastatic non-small cell lung cancer.

Sharman Moser S, Yaari S, Urban D, Apter L, Passwell N, Teper G, Chodick G, Siegelmann-Danieli N. Sharman Moser S, et al. Among authors: apter l. Cancer Epidemiol. 2022 Aug;79:102156. doi: 10.1016/j.canep.2022.102156. Epub 2022 May 17. Cancer Epidemiol. 2022. PMID: 35594797

4

The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer.

Sharman Moser S, Tanser F, Siegelmann-Danieli N, Apter L, Chodick G, Solomon J. Sharman Moser S, et al. Among authors: apter l. J Pharm Policy Pract. 2023 Feb 16;16(1):22. doi: 10.1186/s40545-023-00529-0. J Pharm Policy Pract. 2023. PMID: 36797806 Free PMC article. Review.

5

Real-world outcomes of patients with metastatic endocrine-responsive breast cancer receiving palbociclib-based combinations.

Moser SS, Mazursky OF, Shalev H, Apter L, Chodick G, Siegelmann-Danieli N. Moser SS, et al. Among authors: apter l. Future Oncol. 2023 Jul;19(21):1473-1483. doi: 10.2217/fon-2023-0176. Epub 2023 Aug 2. Future Oncol. 2023. PMID: 37529919 Free article.

6

Time on Treatment and Survival Outcomes for Patients Treated With First-line Osimertinib vs. Other Tyrosine Kinase Inhibitors, for EGFR Mutation-positive Metastatic Non-small Cell Lung Cancer: Real-world Experience Data.

Moser SS, Apter L, Solomon J, Chodick G, Wollner M, Siegelmann-Danieli N. Moser SS, et al. Among authors: apter l. Anticancer Res. 2024 Jan;44(1):257-265. doi: 10.21873/anticanres.16809. Anticancer Res. 2024. PMID: 38159972

7

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting.

Sharman Moser S, Apter L, Livnat I, Ginsburg R, Yarden A, Drori M, Drizon A, Chodick G, Siegelmann-Danieli N. Sharman Moser S, et al. Among authors: apter l. Breast Cancer (Dove Med Press). 2024 Mar 6;16:105-116. doi: 10.2147/BCTT.S439158. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 38464505 Free PMC article.

8

Healthcare resource utilization and associated cost in patients with metastatic non-small cell lung cancer treated in the immunotherapy era.

Apter L, Sharman Moser S, Gazit S, Chodick G, Hoshen M, Greenberg D, Siegelmann-Danieli N. Apter L, et al. Oncologist. 2024 Sep 28:oyae240. doi: 10.1093/oncolo/oyae240. Online ahead of print. Oncologist. 2024. PMID: 39340826 Free article.

9

Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancer.

Sharman Moser S, Yaari S, Apter L, Poellinger B, Rheenen M, Arunachalam A, Chodick G, Hoshen M, Gazit S, Siegelmann-Danieli N. Sharman Moser S, et al. Among authors: apter l. Cancer Epidemiol. 2024 Dec;93:102678. doi: 10.1016/j.canep.2024.102678. Epub 2024 Oct 1. Cancer Epidemiol. 2024. PMID: 39357215 Free article.

10

Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era.

Apter L, Sharman Moser S, Arunachalam A, Gazit S, Hoshen M, Chodick G, Siegelmann-Danieli N. Apter L, et al. Front Oncol. 2024 Oct 25;14:1442909. doi: 10.3389/fonc.2024.1442909. eCollection 2024. Front Oncol. 2024. PMID: 39512773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters